Doctor profile · Federal record
Dr. Michael Mawby, M.D.
Rheumatology Physician (CMS: Rheumatology) · Traverse City, MI
- NPI 1720084114
- Accepts Medicare
- MIPS 75.0 / 100 · 2023
- 39 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1115 S Union St
Traverse City, MI 496843258
(231) 935-0550
fax (231) 935-0551 - Mailing address
-
Po Box 728
Traverse City, MI 496850728
Credentials & registration
- NPI registered
- June 2005 — 21 yrs on file
- Profile last updated
- March 4, 2014
- Year of graduation
- 1987 — 39 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State license (1)
- Michigan #4301051186
- Medicaid
- MI #4324974
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1720084114. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
21,659
Distinct HCPCS
10
Medicare allowed
$801,839
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 7,925 | 18 | $42 | |
J1745 |
Injection, infliximab, excludes biosimilar, 10 mg | 7,570 | 26 | $33 | |
J0897 |
Injection, denosumab, 1 mg | 4,500 | 54 | $23 | |
96365 |
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 345 | 69 | $60 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 303 | 113 | $170 | |
96372 |
Injection of drug or substance under skin or into muscle | 280 | 89 | $14 | |
36415 |
Insertion of needle into vein for collection of blood sample | 216 | 60 | $8 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 182 | 45 | $122 | |
96415 |
Administration of chemotherapy into vein, each additional hour | 175 | 40 | $27 | |
J3489 |
Injection, zoledronic acid, 1 mg | 60 | 12 | $8 |
In context: peer comparison
Among 1 peers in this city , average services per provider: 1,804. This provider delivers 12× the peer median.Open Payments
Industry payments received
All-time total
$156
Transactions
2
Manufacturers
2
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Amgen Inc. | 1 | $130.72 | |
| Novartis Pharmaceuticals Corporation | 1 | $25.40 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,262
Patients
287
Total drug cost
$1,550,295
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate | Generic | 455 | 128 | $39,925 |
| Methotrexate (Methotrexate Sodium) | Brand | 286 | 89 | $20,948 |
| Prednisone | Generic | 113 | 50 | $1,410 |
| Enbrel Sureclick (Etanercept) | Brand | 67 | 0 | $468,380 |
| Folic Acid | Generic | 59 | 20 | $770 |
| Humira(Cf) Pen (Adalimumab) | Brand | 58 | 0 | $427,334 |
| Enbrel (Etanercept) | Brand | 46 | 0 | $317,952 |
| Allopurinol | Generic | 30 | 0 | $934 |
| Sulfasalazine | Generic | 29 | 0 | $1,423 |
| Sulfasalazine Dr (Sulfasalazine) | Brand | 29 | 0 | $3,120 |
Hospital affiliations
Frequently asked questions
What is Dr. Michael Mawby's medical specialty?
Dr. Michael Mawby practices Rheumatology Physician in Traverse City, MI.
Where does Dr. Michael Mawby practice?
Dr. Michael Mawby practices at 1115 S Union St, Traverse City, MI 496843258. Office phone: 2319350550.
What is Dr. Michael Mawby's NPI?
Dr. Michael Mawby's National Provider Identifier (NPI) is 1720084114, issued by NPPES.
Does Dr. Michael Mawby accept Medicare assignment?
Yes. Dr. Michael Mawby accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Michael Mawby commonly perform?
Top Medicare-reported procedures in 2023: Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0129); Injection, infliximab, excludes biosimilar, 10 mg (HCPCS J1745); Injection, denosumab, 1 mg (HCPCS J0897). Source: CMS Medicare Physician & Other Practitioners file.